Table 1.
Demographic and occupational characteristics of the sample (n=446a).
| Characteristic/Variable | M(SD) or % |
|---|---|
| Respondent Age | 40.4(8.6) |
| Gender | |
| Male | 67% |
| Highest Educational Degree | |
| University | 75% |
| Vocational | 16 |
| High School | 8 |
| Middle School | 2 |
| Professional Title | |
| Psychologist | 21% |
| Narcologist | 47 |
| Social Worker | 21 |
| Peer Support Specialist | 11 |
| Years of substance use disorder treatment experience | 10.2 (7.2) |
| Reside in which Ukraine Region | |
| Central | 21% |
| Northern | 20 |
| Eastern | 20 |
| Southern | 21 |
| Western | 19 |
| Primary Theoretical Orientation | |
| Cognitive-Behavioral Therapy | 40% |
| Do not know | 21 |
| 12-step principles | 19 |
| Family Systems therapy | 9 |
| Motivational Interviewing | 4 |
| Person-centered Therapy | 4 |
| Psychodynamic | 3 |
| Other(e.g., eclectic/combination of therapies) | 1 |
| Levels of care offered at clinical setting | |
| Rehabilitation | 92% |
| Case Management | 90 |
| Inpatient treatment | 89 |
| Detox | 82 |
| Intensive outpatient treatment | 47 |
| Outpatient treatment | 43 |
| Other | 12 |
| Pharmacological treatments offered | |
| Psychiatric medications | 87% |
| Methadone | 61 |
| Buprenorphine | 61 |
| Other | 6 |
| Psychological treatments offered | |
| Harm Reduction | 84% |
| Supportive therapy | 62 |
| Cognitive behavioral therapy | 35 |
| Motivational Interviewing | 35 |
| Other | 7 |
| Patient Populations Served | |
| Primarily adults (18+) | 76% |
| Both adults and adolescents/young people | 23 |
| Primarily adolescents/young people (younger than 18) | 1 |
| Proportion of time spent working with patients from each substance category | |
| Harmful use/dependence syndrome: Alcohol | |
| None | 6% |
| 1–25% | 13 |
| 26–50% | 6 |
| 51–75% | 6 |
| 75–100% | 70 |
| Harmful use/dependence syndrome: Opioids | |
| None | 1% |
| 1–25% | 68 |
| 26–50% | 12 |
| 51–75% | 8 |
| 75–100% | 11 |
| Harmful use/dependence syndrome: Cannabis | |
| None | 6% |
| 1–25% | 78 |
| 26–50% | 15 |
| 51–75% | 1 |
| 75–100% | 1 |
| Harmful use/dependence syndrome: Cocaine | |
| None | 31% |
| 1–25% | 68 |
| 26–50% | 1 |
| 51–75% | 0 |
| 75–100% | 1 |
| Harmful use/dependence syndrome: Synthetic Cathinones | |
| None | 58% |
| 1–25% | 39 |
| 26–50% | 1 |
| 51–75% | 1 |
| 75–100% | 1 |
| Harmful use/dependence syndrome: Hallucinogens | |
| None | 42% |
| 1–25% | 56 |
| 26–50% | 1 |
| 51–75% | 1 |
| 75–100% | 1 |
| Harmful use/dependence syndrome: Sedatives | |
| None | 15% |
| 1–25% | 77 |
| 26–50% | 8 |
| 51–75% | 1 |
| 75–100% | 1 |
| Harmful use/dependence syndrome: Tobacco | |
| None | 35% |
| 1–25% | 12 |
| 26–50% | 41 |
| 51–75% | 11 |
| 75–100% | 1 |
| Harmful use/dependence syndrome: Synthetic Cannabis | |
| None | 63% |
| 1–25% | 34 |
| 26–50% | 2 |
| 51–75% | 1 |
| 75–100% | 1 |
| Harmful use/dependence syndrome: Methamphetamine | |
| None | 38% |
| 1–25% | 58 |
| 26–50% | 2 |
| 51–75% | 2 |
| 75–100% | 1 |
| Proportion of time working with people who have co-occurring PTSD/trauma | |
| None | 14% |
| 1–25% | 49 |
| 26–50% | 33 |
| 51–75% | 3 |
| 75–100% | 1 |
| Beliefs about survey bias | |
| Was neutral | 76% |
| Survey supported a controlled use policy | 21 |
| Survey opposed a controlled use policy | 3 |
a
Number of respondents ranged from 428–446 due to missing data